We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.92B
AUM Growth
-$861M
Cap. Flow
-$1.08B
Cap. Flow %
-56.34%
Top 10 Hldgs %
24.9%
Holding
1,961
New
419
Increased
272
Reduced
381
Closed
669

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$13.6M
2
TSM icon
TSMC
TSM
+$11.4M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$11.3M
4
AMAT icon
Applied Materials
AMAT
+$9.44M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$6.99M

Top Sells

Rank Stock Value
1
KAHC
KKR Acquisition Holdings I Corp.
KAHC
+$30.7M
2
TWTR
Twitter, Inc.
TWTR
+$30.3M
3
Y
Alleghany Corp
Y
+$24.9M
4
CTXS
Citrix Systems Inc
CTXS
+$17M
5
ZEN
ZENDESK INC
ZEN
+$15.3M

Sector Composition

Rank Sector Weight
1 Financials 17.05%
2 Technology 12.34%
3 Consumer Discretionary 8.56%
4 Industrials 7.99%
5 Healthcare 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
801
Danaher
DHR
$147B
$287K 0.01%
+1,219
New +$283K
AVNT icon
802
Avient
AVNT
$4.19B
$284K 0.01%
8,405
-214
-2% -$7.03K
ABCB icon
803
Ameris Bancorp
ABCB
$5.88B
$281K 0.01%
+5,958
New +$298K
FDMT icon
804
4D Molecular Therapeutics
FDMT
$582M
$281K 0.01%
+12,631
New +$195K
KLXE icon
805
KLX Energy Services
KLXE
$46M
$280K 0.01%
16,204
-2,361
-13% -$33.2K
PG icon
806
Procter & Gamble
PG
$340B
$280K 0.01%
+1,846
New +$259K
RRAC
807
DELISTED
Rigel Resource Acquisition Corp.
RRAC
$279K 0.01%
27,100
-29,600
-52% -$301K
OEC icon
808
Orion
OEC
$389M
$278K 0.01%
+15,636
New +$263K
GTES icon
809
Gates Industrial Corporation Ltd.
GTES
$7.19B
$278K 0.01%
+24,343
New +$268K
MLI icon
810
Mueller Industries
MLI
$15.2B
$277K 0.01%
+18,776
New +$300K
BERY
811
DELISTED
Berry Global Group, Inc.
BERY
$276K 0.01%
+4,978
New +$244K
MCD icon
812
McDonald's
MCD
$194B
$276K 0.01%
+1,048
New +$276K
INTC icon
813
Intel
INTC
$492B
$276K 0.01%
10,440
-9,263
-47% -$257K
CL icon
814
Colgate-Palmolive
CL
$74.3B
$276K 0.01%
3,500
-21,064
-86% -$1.58M
KDNY
815
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$275K 0.01%
+10,502
New +$233K
OPTN
816
DELISTED
OptiNose
OPTN
$274K 0.01%
9,877
+10
+0.1% +$380
FLEX icon
817
Flex
FLEX
$44.2B
$274K 0.01%
+16,947
New +$254K
TARS icon
818
Tarsus Pharmaceuticals
TARS
$2.97B
$272K 0.01%
18,565
+1,744
+10% +$28.9K
XLU icon
819
State Street Utilities Select Sector SPDR ETF
XLU
$22.4B
$271K 0.01%
+7,700
New +$262K
GH icon
820
Guardant Health
GH
$22.4B
$271K 0.01%
9,967
-4,739
-32% -$217K
DD icon
821
DuPont de Nemours
DD
$19.1B
$271K 0.01%
+3,146
New +$251K
DOCU
822
DocuSign
DOCU
$11.4B
$271K 0.01%
+4,888
New +$238K
GRPN icon
823
Groupon
GRPN
$933M
$270K 0.01%
+31,502
New +$244K
SMTC icon
824
Semtech
SMTC
$12.2B
$269K 0.01%
+9,388
New +$266K
JPM icon
825
PUT
JPMorgan Chase
JPM
$956B
$268K 0.01%
+2,000
New +$253K
31 32
33
34 35

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Prelude Capital Management held 1,961 positions worth $1.92B, down 31% from $2.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $1.08B in Q4 2022, closing 669 positions and reducing 381 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $30.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in AVEO Pharmaceuticals, Inc. worth $7.55M.

  • Prelude Capital Management's largest Q4 2022 buy was AVEO Pharmaceuticals, Inc.: 504,972 shares worth $7.55M.
  • Prelude Capital Management added most to KE Holdings in Q4 2022, an estimated $13.6M increase.
  • Prelude Capital Management's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $6.9M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $30.7M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.92B portfolio in Q4 2022.
  • Prelude Capital Management opened 419 new positions and closed 669 in Q4 2022.
  • Prelude Capital Management's portfolio value fell 31% quarter-over-quarter to $1.92B.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.